Trial demonstrates beta-palmitate benefits for infant bone strength
date:Dec 12, 2012
, measured by QUS (Sunlight Premier Software, Omnisense BeamMed, Ltd.), plus anthropometric parameters, were measured at randomization, then at 6 and 12 weeks postnatal age.

We are very pleased with the study results, said Yael Lifshitz, Ph.D., director of RD, Enzymotec Infant Nutrition. This clearly indicates that InFat benefits bone strength parameters. Bone speed of sound of the newborns fed the formula with InFat was significantly higher than that of newborns fed the control formula, and co
3/5 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
07/23 13:01